Logo image of SNAX

STRYVE FOODS INC-CLASS A (SNAX) Stock Fundamental Analysis

NASDAQ:SNAX - Nasdaq - US8636852027 - Common Stock - Currency: USD

0.5601  -0.19 (-25.12%)

After market: 0.544 -0.02 (-2.87%)

Fundamental Rating

1

SNAX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 89 industry peers in the Food Products industry. SNAX has a bad profitability rating. Also its financial health evaluation is rather negative. SNAX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SNAX has reported negative net income.
SNAX had a negative operating cash flow in the past year.
In the past 5 years SNAX always reported negative net income.
In the past 5 years SNAX always reported negative operating cash flow.
SNAX Yearly Net Income VS EBIT VS OCF VS FCFSNAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -48.67%, SNAX is not doing good in the industry: 88.37% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -48.67%
ROE N/A
ROIC N/A
ROA(3y)-76.32%
ROA(5y)-83.27%
ROE(3y)-530.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNAX Yearly ROA, ROE, ROICSNAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

The Gross Margin of SNAX (19.67%) is comparable to the rest of the industry.
SNAX's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SNAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.58%
GM growth 5YN/A
SNAX Yearly Profit, Operating, Gross MarginsSNAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

1

2. Health

2.1 Basic Checks

SNAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SNAX has been reduced compared to 1 year ago.
Compared to 5 years ago, SNAX has less shares outstanding
SNAX has a worse debt/assets ratio than last year.
SNAX Yearly Shares OutstandingSNAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
SNAX Yearly Total Debt VS Total AssetsSNAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -7.63, we must say that SNAX is in the distress zone and has some risk of bankruptcy.
SNAX's Altman-Z score of -7.63 is on the low side compared to the rest of the industry. SNAX is outperformed by 90.70% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.63
ROIC/WACCN/A
WACC14.53%
SNAX Yearly LT Debt VS Equity VS FCFSNAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

2.3 Liquidity

SNAX has a Current Ratio of 0.38. This is a bad value and indicates that SNAX is not financially healthy enough and could expect problems in meeting its short term obligations.
SNAX's Current ratio of 0.38 is on the low side compared to the rest of the industry. SNAX is outperformed by 95.35% of its industry peers.
A Quick Ratio of 0.17 indicates that SNAX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.17, SNAX is doing worse than 97.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.17
SNAX Yearly Current Assets VS Current LiabilitesSNAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.98% over the past year.
The Revenue has decreased by -4.32% in the past year.
SNAX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)39.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.83%
Revenue 1Y (TTM)-4.32%
Revenue growth 3Y1.37%
Revenue growth 5YN/A
Sales Q2Q%36.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y52.19%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SNAX Yearly Revenue VS EstimatesSNAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 10M 20M 30M
SNAX Yearly EPS VS EstimatesSNAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SNAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNAX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNAX Price Earnings VS Forward Price EarningsSNAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNAX Per share dataSNAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNAX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STRYVE FOODS INC-CLASS A

NASDAQ:SNAX (2/5/2025, 8:27:45 PM)

After market: 0.544 -0.02 (-2.87%)

0.5601

-0.19 (-25.12%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)04-01 2025-04-01/amc
Inst Owners9.3%
Inst Owner Change-79.59%
Ins Owners32.72%
Ins Owner Change20.47%
Market Cap2.27M
Analysts82.86
Price Target4.08 (628.44%)
Short Float %1.37%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.53%
Min EPS beat(2)13.61%
Max EPS beat(2)41.46%
EPS beat(4)4
Avg EPS beat(4)23.3%
Min EPS beat(4)4.96%
Max EPS beat(4)41.46%
EPS beat(8)7
Avg EPS beat(8)13.42%
EPS beat(12)9
Avg EPS beat(12)6%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.11%
Min Revenue beat(2)-10.73%
Max Revenue beat(2)20.95%
Revenue beat(4)2
Avg Revenue beat(4)-8.3%
Min Revenue beat(4)-43.49%
Max Revenue beat(4)20.95%
Revenue beat(8)2
Avg Revenue beat(8)-12.03%
Revenue beat(12)3
Avg Revenue beat(12)-12.78%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)18.18%
EPS NQ rev (3m)36.36%
EPS NY rev (1m)0%
EPS NY rev (3m)9.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-32.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.82
EYN/A
EPS(NY)-3.74
Fwd EYN/A
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS4.78
BVpS-1.57
TBVpS-4.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.67%
FCFM N/A
ROA(3y)-76.32%
ROA(5y)-83.27%
ROE(3y)-530.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.58%
GM growth 5YN/A
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.28%
Cap/Sales 0.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.17
Altman-Z -7.63
F-Score4
WACC14.53%
ROIC/WACCN/A
Cap/Depr(3y)94.89%
Cap/Depr(5y)97.43%
Cap/Sales(3y)5.97%
Cap/Sales(5y)7.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.83%
EPS Next Y52.19%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.32%
Revenue growth 3Y1.37%
Revenue growth 5YN/A
Sales Q2Q%36.39%
Revenue Next Year14.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.95%
OCF growth 3YN/A
OCF growth 5YN/A